Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier. 2004

Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
Advanced Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan.

The recombinant human serum albumin (rHSA) dimer, which was cross-linked by a thiol group of Cys-34 with 1,6-bis(maleimido)hexane, has been physicochemically characterized. Reduction of the inert mixed-disulfide of Cys-34 beforehand improved the efficiency of the cross-linking reaction. The purified dimer showed a double mass and absorption coefficient, but unaltered molar ellipticity, isoelectric point (pI: 4.8) and denaturing temperature (65 degrees C). The concentration dependence of the colloid osmotic pressure (COP) demonstrated that the 8.5 g dL(-1) dimer solution has the same COP with the physiological 5 g dL(-1) rHSA. The antigenic epitopes of the albumin units are preserved after bridging the Cys-34, and the circulation lifetime of the 125I-labeled variant in rat was 18 h. A total of 16 molecules of the tetrakis[(1-methylcyclohexanamido)phenyl]porphinatoiron(II) derivative (FecycP) is incorporated into the hydrophobic cavities of the HSA dimer, giving an albumin-heme hybrid in dimeric form. It can reversibly bind and release O2 under physiological conditions (37 degrees C, pH 7.3) like hemoglobin or myoglobin. Magnetic circular dichroism (CD) revealed the formation of an O2-adduct complex and laser flash photolysis experiments showed the three-component kinetics of the O2-recombination reaction. The O2-binding affinity and the O2-association and -dissociation rate constants of this synthetic hemoprotein have also been evaluated.

UI MeSH Term Description Entries
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007834 Lasers An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum. Masers,Continuous Wave Lasers,Pulsed Lasers,Q-Switched Lasers,Continuous Wave Laser,Laser,Laser, Continuous Wave,Laser, Pulsed,Laser, Q-Switched,Lasers, Continuous Wave,Lasers, Pulsed,Lasers, Q-Switched,Maser,Pulsed Laser,Q Switched Lasers,Q-Switched Laser
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009997 Osmotic Pressure The pressure required to prevent the passage of solvent through a semipermeable membrane that separates a pure solvent from a solution of the solvent and solute or that separates different concentrations of a solution. It is proportional to the osmolality of the solution. Osmotic Shock,Hypertonic Shock,Hypertonic Stress,Hypotonic Shock,Hypotonic Stress,Osmotic Stress,Hypertonic Shocks,Hypertonic Stresses,Hypotonic Shocks,Hypotonic Stresses,Osmotic Pressures,Osmotic Shocks,Osmotic Stresses,Pressure, Osmotic,Pressures, Osmotic,Shock, Hypertonic,Shock, Hypotonic,Shock, Osmotic,Shocks, Hypertonic,Shocks, Hypotonic,Shocks, Osmotic,Stress, Hypertonic,Stress, Hypotonic,Stress, Osmotic,Stresses, Hypertonic,Stresses, Hypotonic,Stresses, Osmotic
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010782 Photolysis Chemical bond cleavage reactions resulting from absorption of radiant energy. Photodegradation
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism

Related Publications

Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
November 1998, Artificial cells, blood substitutes, and immobilization biotechnology,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
January 1988, Biomaterials, artificial cells, and artificial organs,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
July 2014, Soft matter,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
November 2019, RSC advances,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
January 1986, Pharmaceutica acta Helvetiae,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
January 2008, Clinical laboratory,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
July 1998, Biochemistry,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
December 2010, Drug metabolism and disposition: the biological fate of chemicals,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
January 2000, Bioconjugate chemistry,
Teruyuki Komatsu, and Yukiko Oguro, and Yuji Teramura, and Shinji Takeoka, and Junpei Okai, and Makoto Anraku, and Masaki Otagiri, and Eishun Tsuchida
January 1994, Advances in experimental medicine and biology,
Copied contents to your clipboard!